unknown
Stage
2019
Founded
3
Investors
About
Engrail is a clinical-stage pharmaceutical company developing precision-targeted therapies for neurological and neuropsychiatric disorders.
Explore Engrail's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.